Market Performance
Trading Activity
Aier Eye Hospital (300015.SZ) recorded a flat change of 0 % during the 24‑hour period ending at 07:31 PM Central Europe on Thursday, 22 October 2026.
Current trading price: CNY 7.97.
Current share supply: 9.2 bn.
Market capitalization: CNY 73.6 bn.
Volume traded in the last 24 hours: CNY 465.1 mn.
Change since the previous month‑end: ‑1.36 %.
Technical Indicators
200‑day simple moving average: CNY 8.43.
52‑week high: CNY 12.54 (10 November 2025).
52‑week low: CNY 7.67 (15 October 2026).
Acquisition Announcement
On 21 October 2026, Aier Eye Hospital Group Co., Ltd. announced a 1.2 billion‑yuan acquisition of a Yunnan‑based medical services firm. The key points of the transaction are:
- Purchase Price and Premium
- The acquisition was executed at a substantial premium to the target’s recent trading levels.
- Performance‑Based Framework
- The agreement includes profit targets for the next several years.
- Adjustments to the purchase price are triggered if those targets are not achieved.
- Strategic Rationale
- The purchase expands Aier’s network of optical and refractive clinics in Yunnan, supporting its strategy to strengthen regional service coverage and integrate supply chains.
- Risk Disclosure
- The company highlighted potential risks such as unmet performance commitments, goodwill impairment, and integration challenges.
- It referenced past high‑premium deals that resulted in significant write‑downs when projected earnings were not realized.
Related Stock Movements (Last 24 Hours)
| Stock | Trading Activity | Current Price | Market Cap | P/E Ratio | Notes |
|---|---|---|---|---|---|
| Sichuan Chuantou Energy (600674.SS) | Flat 0 % | CNY 17.25 | CNY 84.5 bn | 16.91 | Share‑holding adjustments; controlling group increased stake via large‑block trades. |
| Satellite Chemical (002648.SZ) | Flat 0 % | CNY 24.54 | CNY 85.1 bn | 7.95 | |
| Guangdong Hec H (600673.SS) | Flat 0 % | CNY 27.52 | CNY 86.1 bn | 2,115.44 | Released Q3 2026 report; disclosed external guarantees; secured large‑scale compute‑service contracts. |
| Tbea (600089.SS) | Flat 0 % | CNY 17.30 | CNY 86.7 bn | 16.69 | WETEX 2026 event highlighted; no direct impact on Tbea’s operations noted. |
| Cspc Pharmaceutical Ltd (1093.HK) | Down ‑2.47 % | HKD 8.36 | HKD 101.8 bn | 11.38 |
Company Overview
Aier Eye Hospital Group Co., Ltd. is a Chinese healthcare provider that operates eye care hospitals and institutions nationwide. Its services include:
- Surgical Procedures: Myopia correction, cataract extraction, glaucoma management, pediatric ophthalmology, lacrimal system interventions, corneal and ocular surface treatments, and eye plastic surgery.
- Geographic Reach: Approximately 200 professional eye hospitals across 30 provinces, with additional branches in Hong Kong and the United States.
- Corporate Profile: Listed on the Shenzhen Stock Exchange (ticker 300015.SZ). IPO was completed on 30 October 2009.
- Online Presence: www.aierchina.com .
The recent acquisition aligns with the company’s ongoing expansion strategy and reinforces its position as a leading provider of comprehensive eye care services in China.
